CHAPEL HILL, N.C., July 19, 2011 /PRNewswire/ -- The Medical Affairs function arguably plays the most critical role in a biopharmaceutical organization with heavy responsibilities across areas such as clinical development, KOL development, scientific publications, and medical education.
Recent regulatory changes have pushed Medical Affairs to the forefront of many organizations' priority list. Smart companies and effective biopharma leaders are looking to this area to help them work effectively with the larger medical community and allow the companies to perform better on behalf of their physician and customer stakeholders.
In fact, according to a recent study from Best Practices, LLC research 37% of Medical Affairs spending, on average, is allocated for medical/clinical research, with the top quartile of respondents spending more than 60% for the clinical function. Meanwhile, medical education takes up 18% of allocations, according to the study.
However, a top challenge still on the minds of Medical Affairs executives is insufficient resources, including budget and headcount, for developing and maintaining an effective Medical Affairs group, according to the study.
"Medical Affairs Resources, Structures & Trends," primary research conducted by Best Practices, LLC's, provides medical affairs executives with recent trends in budget and staffing resources, key challenges and top success factors for the function.
Download a complimentary white paper at http://www3.best-in-class.com/rr1093.htm that includes selected best practices drawn from extensive primary research with executives from 25 leading biopharmaceutical companies.
The full 40-page report contains more than 100 benchmark metrics and 20 executive narratives, providing medical affairs executives with recent trends in budget and staffing resources, key challenges and top success factors for the function.
Key topics of this primary research include:
For more information on this study and other recent primary research studies, contact Cameron Tew, Executive Director of Research, at 919.403.9246 or at email@example.com.
BEST PRACTICES, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Best Practices, LLC has been a leader in pharmaceutical research and consulting for more than 17 years; our clients include 48 of the top 50 pharmaceutical companies.
|SOURCE Best Practices, LLC|
Copyright©2010 PR Newswire.
All rights reserved